Clinical Trials Sponsored by Sichuan University

Total 222476 results

Sichuan University

Recruiting

Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer

NSCLC | PD-1 Inhibitor | Leptomeningeal Metastasis | Low Dose Radiotherapy

China
Sichuan University

Recruiting

Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer

Pancreatic Cancer | Adjuvant Therapy

China
Sichuan University

Not yet recruiting

Billroth II With Braun Anastomosis After Radical Distal Gastrectomy for Gastric Cancer

Gastric Cancer | Surgery | Gastrostomy | Anastomosis
Sichuan University

Not yet recruiting

Effect of TEE-guided Non-fluid Limited Combined With Dobutamine on Hepatic Venous Blood Flow Spectrum

Laparoscopic Hepatectomy

China
Sichuan University

Recruiting

Dual-targeting VEGFR1 and PD-L1 CAR-T for Cancers Patients With Pleural or Peritoneal Metastases

Malignant Ascites | Malignant Peritoneal Effusion | Serous Cavity Metastatises

China
Sichuan University

Recruiting

ChiCGB vs BEAM in High-risk or R/R Lymphomas

Lymphoma, Large B-Cell, Diffuse | Lymphoma, T-Cell

China
Sichuan University

Recruiting

Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell Transplantation

Hematologic Malignancy

China
Sichuan University

Not yet recruiting

Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors

Melanoma | Carcinoma | Colorectal Cancer | Bladder Cancer

China
Sichuan University

Recruiting

CXCR4 Modified Anti-BCMA CAR T Cells for Multiple Myeloma

Multiple Myeloma

China
Sichuan University

Recruiting

Dual-targeting HER2 and PD-L1 CAR-T for Cancers With Pleural or Peritoneal Metastasis

Pleural Effusion, Malignant | Peritoneal Carcinoma Metastatic

China
Sichuan University

Recruiting

ATG-008 Combined With Toripalimab in Advanced Solid Tumors

Advanced Solid Tumor

China
Sichuan University

Recruiting

Personalized DC Vaccine for Postoperative Cancer

Hepatocellular Carcinoma | Gastric Cancer | Non-Small-Cell Lung Cancer | Colon Rectal Cancer

China
Sichuan University

Active, not recruiting

EpCAM CAR-T for Treatment of Advanced Solid Tumors

Breast Cancer Recurrent | Malignant Neoplasm of Nasopharynx TNM Staging Distant Metastasis (M) | Gastric Cancer With Metastasis

China
Sichuan University

Unknown

Chidamide Combined With Clad/Gem/Bu With AutoSCT in R/R Diffuse Large B Cell Lymphoma

Lymphoma

China
Sichuan University

Unknown

Personalized DC Vaccine for Lung Cancer (SKLB1608)

Carcinoma, Non-Small-Cell Lung

China
Sichuan University

Unknown

GLIDE Regimen Followed by ASCT for Aggressive NK/T Cell Lymphoma

Lymphoma, Extranodal NK-T-Cell

China
Sichuan University

Completed

Effect of Intra-cuff Lidocaine and Tetracaine on Tracheal Tube-induced Emergence Phenomena

Pharyngitis

China
Sichuan University

Recruiting

Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal Cancer

Esophageal Cancer

China
Sichuan University

Not yet recruiting

Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors

Solid Tumor
Sichuan University

Not yet recruiting

Effects of Aromatherapy on Anxiety and Pain During Dental Treatments in Adults: a Randomized Controlled Clinical Trial

Dental Anxiety
Sichuan University

Not yet recruiting

Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC

Pancreatic Cancer

China
Sichuan University

Recruiting

Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure：Phase I/II (WU-KONG36)

Non Small Cell Lung Cancer

China
Sichuan University

Recruiting

Short-term Blinatumomab as a Bridge Therapy for Allo-HSCT in Low Burden B-ALL

Leukemia, Lymphoid

China
Sichuan University

Not yet recruiting

Dual-targeting CLDN18.2 and PD-L1 CAR-T for Patients With CLDN18.2-positive Advanced Solid Tumors

Advanced Solid Tumor

China
Sichuan University

Recruiting

Chidamide Prevents Recurrence of High-risk AML After Allo-HSCT

Leukemia, Myeloid, Acute

China
Sichuan University

Recruiting

Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.

NSCLC | PD-1 Inhibitor | Stereotactic Body Radiotherapy | Low Dose Radiotherapy

China
Sichuan University

Not yet recruiting

The Effectiveness and Safety of Camrelizumab/Lenvatinib Combined With TACE in Patients With Borderline Resectable HCC

Carrelizumab Plus Lenvatinib Combined With TACE | Borderline Resectable Hepatocellular Carcinoma

China
Sichuan University

Not yet recruiting

Tumor Antigen-sensitized DC Vaccine as an Adjuvant Therapy for Esophagus Cancer

Carcinoma | Esophagus Cancer

China
Sichuan University

Enrolling by invitation

Evaluate Safety, Whole-Body Distribution and Radiation Dosimetry in Metastatic Castration Resistant Prostate Cancer

Metastatic Prostate Cancer

China
Sichuan University

Unknown

Conversion Therapy With Sintilimab Plus CAPOX in Patients With Unresectable Locally Advanced or Limited Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction (CTSCAPOXSEA)

Metastatic Gastric Cancer | Gastroesophageal Junction Adenocarcinoma | Stomach Adenocarcinoma | Locally Advanced Unresectable Gastric Adenocarcinoma

China
Sichuan University

Unknown

Fruquintinib as Second-line Treatment for Advanced/Metastatic Biliary Tract Adenocarcinoma (FSTAMBTA)

Biliary Tract Adenocarcinoma

China
Sichuan University

Unknown

Ruxolitinib Plus LVP in Patients With R/R ETP-ALL

Acute T Cell Leukemia
Sichuan University

Completed

Phase I Trial of Emulsified Isoflurane

Adverse Effect of Intravenous Anesthetics

China
Sichuan University

Completed

Hybrid-everted Versus Hand-sewn or Stapled Esophagogastrostomy in Prevention of Anastomotic Stricture

Esophageal Neoplasms | Surgical Stomas
Sichuan University

Recruiting

Tumor Treating Fields for Newly Diagnosed Glioblastoma: Two Emulated Trials With Chinese Multi-Hospital Based Real-World Data

Glioblastoma Multiforme

China
Sichuan University

Recruiting

Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC

Lung Cancer | Extensive-stage Small-cell Lung Cancer

China
Sichuan University

Not yet recruiting

HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis

Gastric Cancer | Peritoneal Metastases
Sichuan University

Not yet recruiting

Compared Unidirectional Valve Apparatus and Occluding the Non-ventilated Endobronchial Lumen for Lung Collapse.

Video-assisted Thoracoscopic Surgery | One-Lung Ventilation

China
Sichuan University

Not yet recruiting

Blinatumomab Prevents Recurrence of R/R ALL After Allo-HSCT

Leukemia, Lymphoid

China
Sichuan University

Not yet recruiting

MAP-guided Preemptive Therapy of aGvHD by Ruxolitinib

GVHD | Acute Stem Cell Transplant Complications

China
Sichuan University

Not yet recruiting

Immune Reconstitution After Allo-HSCT and Blinatumomab

Leukemia, Lymphoid
Sichuan University

Not yet recruiting

Gemox Combined With Anlotinib and Sintilimab in Advanced cHCC-ICC

Combined Hepatocellular Cholangiocarcinoma
Sichuan University

Recruiting

Dead Mesenchymal Stem Cells for Radiation Lung Injury

Radiation Lung Injury

China
Sichuan University

Not yet recruiting

To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

Gastric Cancer
Sichuan University

Recruiting

Fractionated Busulfan Conditioning Regimen for Allo-HSCT in Non-remission Myeloid Malignancies

Myeloid Malignancies

China
Sichuan University

Recruiting

Study of Low-Dose Radiotherapy Concurrent Cisplatin/Carboplatin Plus Etoposide With Serplulimab for Patients With ES-SCLC

Extensive-stage Small-cell Lung Cancer

China
Sichuan University

Recruiting

MAP-guided Preemptive Therapy of aGvHD

Stem Cell Transplant Complications | GVHD,Acute

China
Sichuan University

Not yet recruiting

A Translational Study of Tumor Antigen-pulsed DC Vaccine for ESCC

Esophageal Squamous Cell Carcinoma

China
Sichuan University

Unknown

Sorafenib Plus Toripalimab for Unresectable HCC With Portal Vein Tumor Thrombus (STUHCCPVTT)

Unresectable Hepatocellular Cancer | Portal Vein Tumor Thrombus
Sichuan University

Unknown

A Prospective Study of Monitoring Immune Response in Locally Advanced Cervix Cancer

Cervical Cancer

China

3

Subscribe